{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:48:15Z","timestamp":1791316095896,"version":"4.3.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5,15]]},"DOI":"10.1097\/qad.0b013e328346bd3e","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T06:06:14Z","timestamp":1303193174000},"page":"1057-1064","source":"Crossref","is-referenced-by-count":106,"title":["Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)"],"prefix":"10.1097","volume":"25","author":[{"given":"Ian","family":"McGowan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailazarid","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Bruder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Febo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice A","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbra A","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla","family":"Husnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Livant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210130","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/01.aids.0000183129.16830.06","article-title":"Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey","volume":"19","author":"Pettifor","year":"2005","journal-title":"AIDS"},{"key":"R2-6-20210130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/QCO.0b013e328334fe70","article-title":"Microbicides for HIV prevention: reality or hope?","volume":"23","author":"McGowan","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"R3-6-20210130","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool","year":"2010","journal-title":"Science"},{"key":"R4-6-20210130","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/mp050023q","article-title":"Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention","volume":"2","author":"McCarthy","year":"2005","journal-title":"Mol Pharm"},{"key":"R5-6-20210130","doi-asserted-by":"crossref","first-page":"e12309","DOI":"10.1371\/journal.pone.0012309","article-title":"Structure activity relationship of dendrimer microbicides with dual action antiviral activity.","volume":"5","author":"Tyssen","year":"2010","journal-title":"PLoS One"},{"key":"R6-6-20210130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/OLQ.0b013e3181bc0aac","article-title":"Safety, tolerability, and pharmacokinetics of SPL7013 gel (VivaGel): a dose ranging, phase I study","volume":"37","author":"O'Loughlin","year":"2010","journal-title":"Sex Transm Dis"},{"key":"R7-6-20210130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/QAI.0b013e318198a7e6","article-title":"A randomized controlled trial of the safety of candidate microbicide SPL7013 gel when applied to the penis","volume":"50","author":"Chen","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-6-20210130","doi-asserted-by":"crossref","first-page":"e16258","DOI":"10.1371\/journal.pone.0016258","article-title":"A phase I randomized placebo controlled trial of the safety of 3% SPL7013 gel (VivaGel(R)) in healthy young women administered twice daily for 14 days","volume":"6","author":"Cohen","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"R9-6-20210130","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/QAI.0b013e3181e3a922","article-title":"Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials","volume":"54","author":"Rudy","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-6-20210130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/aid.2005.21.207","article-title":"SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques","volume":"21","author":"Jiang","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R11-6-20210130","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1128\/AAC.47.12.3784-3788.2003","article-title":"Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes","volume":"47","author":"Bernstein","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"R12-6-20210130","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.44.9.2471-2474.2000","article-title":"Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection","volume":"44","author":"Bourne","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-6-20210130","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1128\/AAC.50.5.1696-1700.2006","article-title":"Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model","volume":"50","author":"Patton","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R14-6-20210130","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/QAD.0b013e32832b4271","article-title":"The safety of candidate vaginal microbicides since nonoxynol-9: a systematic review of published studies","volume":"23","author":"Poynten","year":"2009","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201105150-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:24:04Z","timestamp":1786044244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201105150-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,15]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328346bd3e","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,15]]}}}